Neurogene Inc. Shareholders' Equity
Neurogene Inc. (NGNE) had Shareholders' Equity of $217.13 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $217.13M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $237.78M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $264.89M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $265.54M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $217.13M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $237.78M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $264.89M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $265.54M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $273.25M 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $291.80M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $310.38M 10-Q · filed 2026-08-11 | |
| 2024-09-30 | $137.41M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $155.01M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $170.78M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $186.02M 10-K · filed 2026-03-24 | |
| 2023-09-30 | -$183.21M 10-Q · filed 2024-11-18 | $75.23M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$169.05M 10-Q · filed 2024-11-18 | $79.58M 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$157.60M 10-Q · filed 2024-11-18 | $81.36M 10-Q · filed 2023-05-08 |
| 2022-12-31 | -$145.74M 10-K · filed 2025-03-24 | $94.33M 10-K · filed 2023-03-20 |
| 2022-09-30 | $105.65M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $116.71M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $130.09M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | -$91.88M 10-K · filed 2024-03-18 | $142.86M 10-K · filed 2022-03-01 |
| 2021-09-30 | $154.87M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $167.07M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $178.97M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $191.22M 10-K · filed 2023-03-20 | |
| 2020-09-30 | $200.34M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $128.70M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $137.12M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $141.69M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $66.88M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $72.33M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $71.54M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $72.67M 10-K · filed 2021-03-25 | |
| 2018-09-30 | $76.72M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $90.68M 10-Q · filed 2019-11-13 | |
| 2018-03-31 | $85.83M 10-Q · filed 2019-08-01 | |
| 2017-12-31 | $98.89M 10-K · filed 2020-03-12 | |
| 2017-09-30 | $114.09M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $124.61M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $136.94M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $144.66M 10-K · filed 2020-03-12 | |
| 2016-09-30 | $155.36M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $92.09M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $102.39M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $108.42M 10-K · filed 2019-03-07 | |
| 2015-09-30 | $114.03M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $25.81M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $30.08M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $36.15M 10-K · filed 2018-03-12 | $36.15M 10-K · filed 2015-03-16 |
| 2014-09-30 | $43.98M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $50.02M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $55.10M 10-Q · filed 2014-05-13 | |
| 2014-03-12 | -$65.39M 10-K · filed 2015-03-16 | -$68.78M 10-Q · filed 2014-05-13 |
| 2013-12-31 | -$65.69M 10-K · filed 2017-03-09 | -$65.69M 10-Q · filed 2014-05-13 |
| 2012-12-31 | -$51.10M 10-K · filed 2016-03-14 | -$51.10M 10-Q · filed 2014-05-13 |
| 2011-12-31 | -$39.31M 10-K · filed 2015-03-16 | |
| 2010-12-31 | -$25.11M 10-Q · filed 2014-05-13 | |
| 2009-12-31 | -$14.11M 10-Q · filed 2014-05-13 | |
| 2008-12-31 | -$8.93M 10-Q · filed 2014-05-13 | |
| 2007-12-31 | -$2.43M 10-Q · filed 2014-05-13 | |
| 2006-12-31 | $10.71K 10-Q · filed 2014-05-13 | |
| 2005-12-31 | -$31.01K 10-Q · filed 2014-05-13 | |
| 2004-12-31 | -$11.39K 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |